CARLSBAD, Calif., May 1, 2007 (PRIME NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), a leading medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, announced today that James R. Glynn was elected to Alphatec's board of directors. Mr. Glynn's appointment increases Alphatec's Board of Directors in size from five Directors to six, and increases the number of independent directors from two to three. Mr. Glynn will also serve as the Chairman of Alphatec's Audit Committee.
